{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T01:50:25Z","timestamp":1773539425845,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302237"],"award-info":[{"award-number":["82302237"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital of Sichuan University","doi-asserted-by":"publisher","award":["ZYJC21029"],"award-info":[{"award-number":["ZYJC21029"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital of Sichuan University","doi-asserted-by":"publisher","award":["ZYJC23016"],"award-info":[{"award-number":["ZYJC23016"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1580"],"award-info":[{"award-number":["2023NSFSC1580"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2025.118542","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:47:49Z","timestamp":1767455269000},"page":"118542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of a novel tau PET tracer: Design, synthesis, radio-labeling, and preclinical evaluations"],"prefix":"10.1016","volume":"305","author":[{"given":"Dongping","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118542_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer's disease: strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118542_bib2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.1090349","article-title":"Looking backward to move forward: early detection of neurodegenerative disorders","volume":"302","author":"DeKosky","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118542_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2025.118542_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archneur.60.5.729","article-title":"Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment","volume":"60","author":"Guillozet","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejmech.2025.118542_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jnen\/61.1.33","article-title":"Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy","volume":"61","author":"Takahashi","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2025.118542_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for alzheimer disease: current status and future directions","volume":"19","author":"Congdon","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2025.118542_bib7","article-title":"Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to alzheimer's disease","volume":"7","author":"Tissot","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejmech.2025.118542_bib8","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in alzheimer's disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain : a journal of neurology"},{"key":"10.1016\/j.ejmech.2025.118542_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.672077","article-title":"Association of tau pathology with clinical symptoms in the subfields of hippocampal formation","volume":"13","author":"Ge","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2025.118542_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2025.118542_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3233\/JAD-160316","article-title":"In vivo patterns of tau pathology, Amyloid-\u03b2 burden, and neuronal dysfunction in clinical variants of alzheimer's disease","volume":"55","author":"Dronse","year":"2017","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejmech.2025.118542_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jnen\/nlz141","article-title":"Primary tau pathology, not copathology, correlates with clinical symptoms in PSP and CBD","volume":"79","author":"Robinson","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2025.118542_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","article-title":"Tau imaging: early progress and future directions","volume":"14","author":"Villemagne","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2025.118542_bib14","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.21-24-j0004.2001","article-title":"Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in alzheimer's disease","volume":"21","author":"Agdeppa","year":"2001","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejmech.2025.118542_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1471-4159.2009.05996.x","article-title":"Interaction of the amyloid imaging tracer FDDNP with hallmark alzheimer's disease pathologies","volume":"109","author":"Thompson","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2025.118542_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40336-018-0290-y","article-title":"The development and validation of tau PET tracers: current status and future directions","volume":"6","author":"Okamura","year":"2018","journal-title":"Clin Transl Imaging"},{"key":"10.1016\/j.ejmech.2025.118542_bib17","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.118542_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron emission tomography imaging with [18f]flortaucipir and postmortem assessment of alzheimer disease neuropathologic changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2025.118542_bib19","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s00259-015-3035-4","article-title":"[(18)F]THK-5117 PET for assessing neurofibrillary pathology in alzheimer's disease","volume":"42","author":"Harada","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2025.118542_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nucmedbio.2016.12.004","article-title":"Development of [(11)C]\/[(3)H]THK-5351 - a potential novel carbon-11 tau imaging PET radioligand","volume":"46","author":"Stepanov","year":"2017","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2025.118542_bib21","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2967\/jnumed.114.139550","article-title":"Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology","volume":"55","author":"Hashimoto","year":"2014","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"key":"10.1016\/j.ejmech.2025.118542_bib22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2025.118542_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1017\/cjn.2014.15","article-title":"Developments in tau PET imaging","volume":"41","author":"Zimmer","year":"2014","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ejmech.2025.118542_bib24","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","article-title":"[(18)F]T807, a novel tau positron emission tomography imaging agent for alzheimer's disease","volume":"9","author":"Xia","year":"2013","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejmech.2025.118542_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-122059","article-title":"Early clinical PET imaging results with the novel PHF-Tau radioligand [F-18]-T807","volume":"34","author":"Chien","year":"2013","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejmech.2025.118542_bib26","first-page":"232","article-title":"Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding","volume":"10","author":"Lemoine","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejmech.2025.118542_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain","volume":"9","author":"Ng","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ejmech.2025.118542_bib28","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1177\/0271678X19879226","article-title":"Test-retest repeatability of [(18)F]Flortaucipir PET in alzheimer's disease and cognitively normal individuals","volume":"40","author":"Timmers","year":"2020","journal-title":"J. Cerebr. Blood Flow Metabol. : official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.ejmech.2025.118542_bib29","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2967\/jnumed.123.265593","article-title":"Preclinical characterization of the tau PET tracer [(18)F]SNFT-1: comparison of tau PET tracers","volume":"64","author":"Harada","year":"2023","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"key":"10.1016\/j.ejmech.2025.118542_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","article-title":"In vivo quantification of neurofibrillary tangles with [(18)F]MK-6240","volume":"10","author":"Pascoal","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ejmech.2025.118542_bib31","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2967\/jnumed.118.209916","article-title":"Characterization of 3 novel tau radiopharmaceuticals, (11)C-RO-963, (11)C-RO-643, and (18)F-RO-948, in healthy controls and in alzheimer subjects","volume":"59","author":"Wong","year":"2018","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"key":"10.1016\/j.ejmech.2025.118542_bib32","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","article-title":"Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in alzheimer's disease and other tauopathies","volume":"46","author":"Kroth","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2025.118542_bib33","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00259-019-04399-0","article-title":"[(18)F]GTP1 (genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease","volume":"46","author":"Sanabria Boh\u00f3rquez","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2025.118542_bib34","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1177\/0271678X211031035","article-title":"Evaluation of [(18)F]-JNJ-64326067-A tau PET tracer in humans","volume":"41","author":"Baker","year":"2021","journal-title":"J. Cerebr. Blood Flow Metabol. : official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.ejmech.2025.118542_bib35","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/acs.jmedchem.6b01173","article-title":"Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as potential tau pathology PET tracers for Alzheimer's disease","volume":"60","author":"Rombouts","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118542_bib36","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/acs.jmedchem.6b00166","article-title":"Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): a positron Emission Tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs)","volume":"59","author":"Walji","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118542_bib37","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/acs.jmedchem.6b00166","article-title":"Discovery of 6-(Fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([(18)F]-MK-6240): a positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs)","volume":"59","author":"Walji","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118542_bib38","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1021\/acs.jmedchem.7b00632","article-title":"Identification of three novel radiotracers for imaging aggregated tau in alzheimer's disease with positron emission tomography","volume":"60","author":"Gobbi","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118542_bib39","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1021\/acs.jmedchem.8b01759","article-title":"Discovery of N-(4-[(18)F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a new promising tau positron emission tomography imaging tracer","volume":"62","author":"Rombouts","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118542_bib40","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/jm400312y","article-title":"Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand","volume":"56","author":"Zhang","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118542_bib41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/cn100007x","article-title":"Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118542_bib42","doi-asserted-by":"crossref","first-page":"19282","DOI":"10.1002\/anie.202008528","article-title":"Holistic prediction of the pKa in diverse solvents based on a machine-learning approach","volume":"59","author":"Yang","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118542_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/acs.jcim.9b00718","article-title":"Systematic modeling of log D7.4 based on ensemble machine learning, group contribution, and matched molecular pair analysis","volume":"60","author":"Fu","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118542_bib44","doi-asserted-by":"crossref","first-page":"14527","DOI":"10.1021\/acs.jmedchem.2c00859","article-title":"Fused Cycloheptatriene-BODIPY is a high-performance near-infrared probe to image tau tangles","volume":"65","author":"Xie","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118542_bib45","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1021\/acs.molpharmaceut.3c00717","article-title":"Synthesis and bioevaluation of 2-Styrylquinoxaline derivatives as Tau-PET tracers","volume":"20","author":"Wu","year":"2023","journal-title":"Mol. Pharm."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425013078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425013078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T01:13:22Z","timestamp":1773537202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425013078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"alternative-id":["S0223523425013078"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118542","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel tau PET tracer: Design, synthesis, radio-labeling, and preclinical evaluations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118542"}}